Primary information |
---|
CancerPPD ID | 2231 |
PMID | None |
YEAR | 2005 |
SEQUENCE | MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG |
LENGTH | 38 |
NAME | SB-37 AC |
C-ter Modification | Free |
N-ter Modification | Free |
Linear/Cyclic | Linear |
L/D/Mix | L |
Non-Natural | None |
NATURE | Anticancer |
ACTIVITY | LD50 =120 µg/ml |
SOURCE | FLAK peptides |
Cancer Type | Skin Cancer |
ASSAY | MTT/MTS assay |
Patent ID | US_06875744_B2 |
Tissue | Skin |
CELL LINE | BMKC |
TEST TIME | 24-h |
Secondary information |
---|
STRUCTURE | |
DSSP states | CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC |
SMILES | N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O |
External Links |
---|
PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
NA | 2i4qA | NA | >sp_B2S6E8_COBQ_BRUA1CobyricacidsynthaseOS=Bruc | NA | >tr_E7QYF0_E7QYF0_9EURYPutativeuncharacterizedproteinOS=HaladaptatuspaucihalophilusDX253GN=ZOD2009_1 | NA | 72472 |
|